Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Cross Country Healthcare Inc is a medical care facilities business based in the US. Cross Country Healthcare shares (CCRN) are listed on the NASDAQ and all prices are listed in US Dollars. Cross Country Healthcare employs 2,250 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Active traders
| Latest market close | $21.30 |
|---|---|
| 52-week range | $14.23 - $30.40 |
| 50-day moving average | $18.24 |
| 200-day moving average | $21.55 |
| Wall St. target price | $34.33 |
| PE ratio | 4.6082 |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $4.62 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $21.3 from 2022-07-05
| 1 week (2022-06-30) | 2.26% |
|---|---|
| 1 month (2022-06-07) | 14.33% |
| 3 months (2022-04-06) | 8.18% |
| 6 months (2022-01-07) | -17.92% |
| 1 year (2021-07-07) | 38.58% |
|---|---|
| 2 years (2020-07-07) | 265.98% |
| 3 years (2019-07-05) | 134.32% |
| 5 years (2017-07-06) | 75.02% |
Valuing Cross Country Healthcare stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Cross Country Healthcare's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Cross Country Healthcare's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 5x. In other words, Cross Country Healthcare shares trade at around 5x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Cross Country Healthcare's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.4444. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Cross Country Healthcare's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Cross Country Healthcare's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $225.9 million.
The EBITDA is a measure of a Cross Country Healthcare's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $2.1 billion |
|---|---|
| Operating margin TTM | 10.09% |
| Gross profit TTM | $375 million |
| Return on assets TTM | 19.83% |
| Return on equity TTM | 65.89% |
| Profit margin | 8.17% |
| Book value | $9.51 |
| Market capitalisation | $813.6 million |
TTM: trailing 12 months
We're not expecting Cross Country Healthcare to pay a dividend over the next 12 months.
Over the last 12 months, Cross Country Healthcare's shares have ranged in value from as little as $14.23 up to $30.4. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cross Country Healthcare's is 1.1034. This would suggest that Cross Country Healthcare's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Cross Country Healthcare, Inc. provides talent management and other consultative services for healthcare clients in the United States. The company operates in two segments, Nurse and Allied Staffing and Physician Staffing. The Nurse and Allied Staffing segment offers traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, local nurses, and allied staffing; staffing solutions for registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and clinical and non-clinical professionals on long-term contract assignments, as well as workforce solutions, including MSP, RPO, and consulting services. It also provides retained search services for healthcare professionals, as well as contingent search and recruitment process outsourcing services. This segment serves public and private acute care and non-acute care hospitals, government facilities, local and national healthcare plans, managed care providers, public and charter schools, outpatient clinics, ambulatory care facilities, physician practice groups, and other healthcare providers under the Cross Country brand. The Physician Staffing segment provides physicians in various specialties, certified registered nurse anesthetists, nurse practitioners, and physician assistants under the Cross Country Locums brand as independent contractors on temporary assignments at various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations.
Everything we know about the Citrine Global IPO, plus information on how to buy in.
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.